03390nam 2200445 450 991013719710332120221206100707.0(CKB)3710000000526120(SSID)ssj0001683375(PQKBManifestationID)16509608(PQKBTitleCode)TC0001683375(PQKBWorkID)15037986(PQKB)10642306(WaSeSS)IndRDA00056706(EXLCZ)99371000000052612020160829d2015 uy 0engur||#||||||||txtrdacontentcrdamediacrrdacarrierNew frontiers in the neuropsychopharmacology of mental illness /topic editors: Thibault Renoir, Laurence Lanfumey and Maarten van den BuuseFrance :Frontiers Media SA,20151 online resource (254 pages) illustrations; digital file(s)Frontiers Research TopicsBibliographic Level Mode of Issuance: MonographIncludes bibliographical references.In recent years, mental illnesses have become recognized as a huge emotional and financial burden to the individual, their relatives and society at large. Stress-related and mood disorders as well as psychoactive substance abuse are among the disorders associated with most disability in high income countries. Suicide, which is often attributed to some underlying mental disorders, is a leading cause of death among teenagers and young adults. At the same time, mental disorders pose some of the toughest challenges in neuroscience research. There are many different categories of mental disorder as defined and classified by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and the International Statistical Classification of Diseases 10th Revision (ICD-10). Despite the ongoing improvements of those widely used manuals, the validity and reliability of their diagnoses remain a constant debate. However, it has now become accepted by the scientific community that mental disorders can arise from multiple sources. In that regard, both clinical and animal studies looking at gene-environment interactions have helped to better understand the mechanisms involved in the pathophysiology as well as the discovery of treatments for mental disorders. This Research Topic aims to cover recent progress in research studying how genetic make-up and environmental factors (such as stress paradigm or pharmacological treatment) can contribute to the development of mental disorders such as anxiety, depression, and schizophrenia. This Research Topic also seeks to highlight studies looking at affective-like disorders following the intake of drugs of abuse. We also welcome all research articles, review papers, brief communications, and commentary on topics related to the broad field of Neuropsychopharmacology.Pharmacy, Therapeutics, & PharmacologyHILCCHealth & Biological SciencesHILCCPharmacy, Therapeutics, & PharmacologyHealth & Biological SciencesLanfumey LaurenceBuuse Maarten van denRenoir ThibaultPQKBUkMaJRU9910137197103321New frontiers in the neuropsychopharmacology of mental illness2113010UNINA